Personalized treatment of advanced non-small-cell lung cancer in routine clinical practice

Personalized treatment of patients with advanced non-small-cell lung cancer based on clinical and molecular tumor features has entered clinical routine practice. The 2015 pathological classification of lung cancer mandates immunohistochemical and molecular analysis. Therapeutic strategies focused on...

Descripción completa

Detalles Bibliográficos
Autores principales: Pirker, Robert, Filipits, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821865/
https://www.ncbi.nlm.nih.gov/pubmed/26970967
http://dx.doi.org/10.1007/s10555-016-9612-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821865/
https://www.ncbi.nlm.nih.gov/pubmed/26970967
http://dx.doi.org/10.1007/s10555-016-9612-6

Ejemplares similares